healio.com
43 articles in the TruthFoundry index. Each links out to the original.
- Study finds all five tested rheumatology AI tools require clinician oversight · Research presented at ACR Convergence tested five clinical AI tools, finding all contain errors.
- Rheumatology LLM halves diagnosis time, shows no accuracy improvement · Randomized trial finds LLM cuts rheumatology diagnosis time but does not improve accuracy.
- Time since last COVID booster linked to mortality in immunocompromised patients · Study finds booster recency predicts COVID mortality in hospitalized immunocompromised patients.
- Nipocalimab outperforms placebo in systemic lupus phase 2 clinical trial · Janssen's nipocalimab met key lupus efficacy endpoints at 52 weeks in phase 2 testing.
- Autoimmune rheumatic disease patients have elevated long COVID risk, study finds · Medical study finds 1.5x higher long COVID risk for autoimmune rheumatic disease patients.
- Dermatology clinics can reduce environmental impact through supply chain changes · A study finds that dermatology clinics can reduce their environmental impact by optimizing supply chain practices.
- American College of Rheumatology opposes Medicare, H1-B visa policy changes · ACR leads advocacy against Medicare cuts, H1-B fees, and NIH grant political oversight plans.
- CDC Deputy Director Jennifer Shuford Resigns After Four Months · CDC deputy director Jennifer Shuford resigns after 4 months, citing family time.
- Higher B-cell Counts Linked to Toxic Effects Post CAR T-Cell Therapy in Autoimmune Diseases · A study finds higher B-cell counts and IL-6 levels at baseline are associated with cytokine release syndrome after CAR T-cell therapy in autoimmune disease patients.
- FDA approves Evoxac oral solution for Sjögren’s disease dry mouth · FDA approved Cosette Pharmaceuticals' Evoxac oral solution for Sjögren’s disease dry mouth symptoms.
- Leonard Calabrese discusses rheumatology advances and AI in practice · Leonard Calabrese reviews rheumatology research, AI discussions, and fibromyalgia findings.
- Evolution of medical records and proposed human-centric AI adjustments · Rheumatology editor proposes adding human context to AI-generated medical notes.
- Updated COVID vaccines reduce hospitalizations in immunocompromised rheumatic patients · Study finds updated COVID vaccines outperform initial series for autoimmune rheumatic patients
- FDA Biosimilar Guideline Changes Fail To Resolve Uptake Barriers · Recent FDA biosimilar approval streamlining has not improved patient access or cost savings.
- Primary care best practices for evaluating joint pain in older adults · Rheumatology expert outlines guidance for PCPs diagnosing inflammatory arthritis in older patients.
- FDA approves brepocitinib first oral dermatomyositis treatment · Brepocitinib becomes first FDA approved oral therapy for dermatomyositis after successful trials.
- Surgeon outlines trainable stress management skills for operating room teams · Ophthalmologist Erin Seefeldt presented surgical stress reduction methods at an ophthalmology conference.
- Study: 75% of Fibromyalgia Patients Remain Undiagnosed · Nearly three-quarters of individuals meeting fibromyalgia criteria were never clinically diagnosed in a large UK study.
- Updated Clinical Guidance Presented For SSc Interstitial Lung Disease · Rheumatologist outlines screening and treatment for systemic sclerosis lung disease at conference.
- Researchers validate global standard classification system for surgical site outcomes · International research team publishes validated DISH classification for surgical wound outcomes.
- B-cell depletion therapies show promise but carry significant safety risks · Experts warn that while B-cell depletion offers remission, profound depletion risks infections and lacks a 'free lunch'.
- Doctor Offers 5-Step Formula for Achievable Goal Setting · Robyn Tiger, MD, outlines a five-step approach to setting effective goals for physicians.
- Novartis CAR-T trial deaths change autoimmune patient consent discussions · Three trial deaths will add risk context to CAR-T therapy patient discussions, researchers state.
- Genetic Study Confirms Fibromyalgia as Central Nervous System Disorder · New genetic evidence from over 2.5 million individuals classifies fibromyalgia as a central nervous system disorder.
- Leonard Calabrese discusses difficult inflammatory disease in Healio video · Leonard Calabrese highlights coverage on immune-mediated inflammatory disease treatments.
- Rheumatologists urged to care for patients with controlled inflammation but persistent symptoms · Editorial argues rheumatologists must address persistent symptoms in difficult-to-treat patients even when inflammation is controlled.
- Calabrese presents GLP-1 anti-inflammatory effects independent of weight loss · Leonard Calabrese presented data showing GLP-1 drugs may act directly as anti-inflammatories.
- Rheumatologist Warns of Errors in Clinical Trial Interpretation · Andreas Kerschbaumer advises caution when interpreting rheumatology clinical trials due to measurement errors and placebo effects.
- SetPoint System shows improving long-term efficacy for rheumatoid arthritis · Jeffrey Curtis presented SetPoint System RA data at the 2026 CCR West conference.
- FDA Grants Fast Track Status to Yutrepia for SSc Raynaud’s Phenomenon · FDA awarded fast track designation to Liquidia's Yutrepia for systemic sclerosis related Raynaud's.